Related Experiment Video
Updated: Apr 24, 2026

10:25
Pan-myeloid Differentiation of Human Cord Blood Derived CD34+ Hematopoietic Stem and Progenitor Cells
Published on: August 9, 2019
9.3K
Intra-apheresis CD34+ cell count: A dynamic approach to predicting peripheral blood stem cell collection yield
Abdullah Alswied1, Linda Song1, Mame Thioye-Sall1
1Department of Transfusion Medicine and Center for Cellular Engineering, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.
Transfusion
|April 23, 2026
Summary
A single intra-apheresis CD34+ measurement accurately predicts peripheral blood stem cell yield. This real-time method surpasses traditional formulas, improving collection efficiency and reducing donor burden.
Area of Science:
- Hematology
- Cellular Therapy
- Biostatistics
Background:
- Optimizing hematopoietic stem cell collection requires accurate peripheral blood stem cell (PBSC) yield prediction.
- Traditional CD34+ cell prediction models often fail to account for cell recruitment during apheresis.
- This study investigated the utility of intra-apheresis CD34+ measurements for enhanced yield prediction.
Purpose of the Study:
- To evaluate the predictive accuracy of a single intra-apheresis CD34+ measurement for PBSC yield.
- To compare the efficacy of intra-apheresis prediction against established pre-apheresis formulas.
- To determine optimal timing for intra-apheresis measurements to improve prediction accuracy.
Main Methods:
- Retrospective analysis of 150 PBSC collections from 123 donors.
- Development of univariable and multivariable linear regression models using intraprocedural CD34+ counts and final yield.
- Validation through bootstrap resampling, cross-validation, and subgroup analyses (age, sex, weight, diagnosis, sampling time).
Main Results:
- Intra-apheresis CD34+ counts strongly correlated with final PBSC yield (R²=0.95).
- High predictive accuracy (R²=0.91-0.99) was maintained across diverse donor subgroups.
- The intra-apheresis model demonstrated superior performance (higher R², lower error) compared to pre-apheresis formulas.
Conclusions:
- A single intra-apheresis CD34+ measurement provides a reliable, real-time prediction of final PBSC yield.
- Measurements taken at or beyond 1.20 processed blood volumes optimize predictive accuracy.
- This intraprocedural approach enhances collection efficiency and minimizes donor inconvenience.

